PVCT

PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (PVCT)

About PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (PVCT)

Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. Its prescription drugs treat several life-threatening cancers including metastatic melanoma, liver cancer, and breast cancer. The company was founded by Eric A. Wachter on January 17, 2002 and is headquartered in Knoxville, TN.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.20
52 Week Low
$0.04
Market cap
41.6M
Dividend yield
0.00%
Volume
--
Avg. volume
153,657
P/E ratio
-8.76

PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.20
52 Week Low
$0.04
Market cap
41.6M
Dividend yield
0.00%
Volume
--
Avg. volume
153,657
P/E ratio
-8.76